Heather Wakelee

Heather Wakelee

Stanford University

H-index: 80

North America-United States

About Heather Wakelee

Heather Wakelee, With an exceptional h-index of 80 and a recent h-index of 62 (since 2020), a distinguished researcher at Stanford University, specializes in the field of Oncology, lung cancer, thymoma, thymic carcinoma.

His recent articles reflect a diverse array of research interests and contributions to the field:

The International Association for the Study of Lung Cancer Early Lung Imaging Confederation open-source deep learning and quantitative measurement initiative

frontiers Research Topics February 2024

Nationwide patterns of incidence and surveillance of second primary lung cancer among long-term lung cancer survivors using SEER Medicare data

A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients …

Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study

Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and Concurrent Chemotherapy for Non–Small-Cell Lung Cancer

Abstract CT239: IMpower010: Updated overall survival and safety results from Asian patients in a Phase III study of adjuvant atezolizumab vs best supportive care in resected …

Heather Wakelee Information

University

Position

Professor of Medicine

Citations(all)

28009

Citations(since 2020)

17541

Cited By

16376

hIndex(all)

80

hIndex(since 2020)

62

i10Index(all)

274

i10Index(since 2020)

198

Email

University Profile Page

Stanford University

Google Scholar

View Google Scholar Profile

Heather Wakelee Skills & Research Interests

Oncology

lung cancer

thymoma

thymic carcinoma

Top articles of Heather Wakelee

Title

Journal

Author(s)

Publication Date

The International Association for the Study of Lung Cancer Early Lung Imaging Confederation open-source deep learning and quantitative measurement initiative

Journal of Thoracic Oncology

Enrico Ruffini

Ramon Rami-Porta

James Huang

Usman Ahmad

Sarit Appel

...

2022/6/1

frontiers Research Topics February 2024

Detection, characterization, and management of plant pathogens

Yi-Nan Ma

Yi-Lin Gu

Jing Liu

Yuqin Zhang

Xinwei Wang

...

2024/2/20

Nationwide patterns of incidence and surveillance of second primary lung cancer among long-term lung cancer survivors using SEER Medicare data

Cancer Research

Chloe C Su

Eunji Choi

Julie T Wu

Allison W Kurian

Michelle C Odden

...

2024/3/22

A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients …

JTO Clinical and Research Reports

Kathryn E Beckermann

Christine M Bestvina

Badi El Osta

Rachel E Sanborn

Hossein Borghaei

...

2024/2/1

Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC

Journal of Thoracic Oncology

Kaiwen Wang

Robyn Du

Nathaniel J Myall

Whitney E Lewis

Natalie Uy

...

2024/3/1

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study

Journal of Thoracic Oncology

Amin H Nassar

So Yeon Kim

Jacqueline V Aredo

Jamie Feng

Frances Shepherd

...

2024/1/24

Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and Concurrent Chemotherapy for Non–Small-Cell Lung Cancer

Clinical Lung Cancer

Caressa Hui

Cesar Marquez

Brianna Lau

Millie Das

Nathaniel J Myall

...

2024/3/1

Abstract CT239: IMpower010: Updated overall survival and safety results from Asian patients in a Phase III study of adjuvant atezolizumab vs best supportive care in resected …

Cancer Research

Jie Wang

Yun Fan

Jian Fang

Jianxing He

Yunpeng Liu

...

2024/4/5

A Novel Therapeutic Approach using CXCR3 Blockade to Treat Immune Checkpoint Inhibitor-mediated Myocarditis

bioRxiv

Yuhsin Vivian Huang

Daniel Lee

Yin Sun

Harrison Chou

Bruce Xu

...

2024

Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer: Protocol for a Bayesian Optimal Phase I/II Trial

Clinical Lung Cancer

Caressa Hui

Eleanor Brown

Samantha Wong

Millie Das

Heather Wakelee

...

2024/3/1

Asian American women’s experiences of discrimination and health behaviors during the COVID-19 pandemic

Journal of Immigrant and Minority Health

Katarina Wang

Alice Guan

Janice Seto

Debora L Oh

Kathie Lau

...

2024/4

THE IMPACT OF ROUTINE CARDIAC TROPONIN I-BASED CARDIOTOXICITY SCREENING ON CLINICAL OUTCOMES IN PATIENTS ON CANCER IMMUNOTHERAPY

medRxiv

Maja Ivanovic

Antonia Chan

Evaline Cheng

Sidra Xu

Carissa Le

...

2024

Risk model‐based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model

Cancer

Eunji Choi

Sophia J Luo

Victoria Y Ding

Julie T Wu

Ashok V Kumar

...

2024/3/1

Cell-free RNA analysis for non-invasive cancer detection and characterization

Cancer Research

Monica C Nesselbush

Bogdan A Luca

Young-Jun Jeon

Isabel Jabara

Catherine B Meador

...

2024/3/22

MA16. 11 Consolidation EGFR-Tyrosine Kinase Inhibitor (TKI) vs. Durvalumab vs. Observation in Unresectable EGFR-Mutant Stage III NSCLC

Journal of Thoracic Oncology

AH Nassar

E Adib

D Kaldas

J Feng

T AbuAli

...

2023/11/1

Software Application Profile: dynamicLM—a tool for performing dynamic risk prediction using a landmark supermodel for survival data under competing risks

International Journal of Epidemiology

Anya H Fries

Eunji Choi

Julie T Wu

Justin H Lee

Victoria Y Ding

...

2023/12/1

Use of machine learning and lay care coaches to increase advance care planning conversations for patients with metastatic cancer

JCO Oncology Practice

Michael F Gensheimer

Divya Gupta

Manali I Patel

Touran Fardeen

Rachel Hildebrand

...

2023/2

Molecular determinants of KRAS p. G12C inhibitor efficacy in advanced NSCLC

Cancer Research

Marcelo V Negrao

Haniel A Araujo

Giuseppe Lamberti

Alissa J Cooper

Teng Zhou

...

2023/4/4

Abstract P055: Risk factors for second primary lung cancer among breast cancer survivors

Cancer Prevention Research

Eunji Choi

Justin Lee

Julie T Wu

Heather A Wakelee

Lidia Schapira

...

2023/1/1

Early-stage lung cancer: using circulating tumor DNA to get personal

Journal of Clinical Oncology

Christine M Bestvina

Marina C Garassino

Joel W Neal

Heather A Wakelee

Maximilian Diehn

...

2023/9/1

See List of Professors in Heather Wakelee University(Stanford University)